In an article published in the Journal of Neurosurgery website, the study results were posted on Neonc Technologies Holdings’ recent animal study looking at the efficacy of using the NEO100 formulation for treating CNS disease in the brain. Malignancies of the CNS are difficult to treat because the blood-brain barrier (BBB) prevents most therapeutics from […]